Sheila Assunção-Talbott

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of Adjunctive Aripiprazole for Schizophrenia or Schizoaffective Disorder Inadequately Treated With Quetiapine or Risperidone Monotherapy

John M. Kane, Christoph U. Correll, Donald Goff et al. · The Journal of Clinical Psychiatry · 2009 · 123 citations

An Open-Label Study of Aripiprazole: Pharmacokinetics, Tolerability, and Effectiveness in Children and Adolescents with Conduct Disorder

Robert L. Findling, Ralph E. Kauffman, Floyd R. Sallee et al. · Journal of Child and Adolescent Psychopharmacology · 2009 · 53 citations

The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: Results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials

Ira D. Glick, Raymond Mankoski, James M. Eudicone et al. · Journal of Affective Disorders · 2009 · 30 citations

Drug Safety, Pivotal Trials, Psychiatry +11

Changes in Positive and Negative Syndrome Scale–Derived Hostility Factor in Adolescents with Schizophrenia Treated with Aripiprazole: <i>Post Hoc</i> Analysis of Randomized Clinical Trial Data

Adelaide S. Robb, William H. Carson, Margaretta Nyilas et al. · Journal of Child and Adolescent Psychopharmacology · 2010 · 16 citations

The efficacy of aripiprazole in the treatment of multiple symptom domains in patients with acute schizophrenia: A pooled analysis of data from the pivotal trials

John M. Kane, Sheila Assunção-Talbott, James M. Eudicone et al. · Schizophrenia Research · 2008 · 11 citations

Pivotal Trials, Acute Schizophrenia, Psychiatry +10